识别和验证白血病抑制因子作为缺血性急性损伤的保护因子
Lemei Hu1, Chen Jiao1, Haiyu Gu2
1Department of Nephrology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Panfu Road, Guangzhou, Guangdong 510000, China.
The American journal of the medical sciences
|September 23, 2024
概括
白血病抑制因子 (LIF) 在急性损伤中起着关键作用,因缺血-再输液损伤 (IRI-AKI). 向LIF可能通过调节亡和氧化应激来为IRI-AKI提供一个有希望的治疗策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 缺血-再输液损伤 (IRI) 是急性损伤 (AKI) 的主要原因之一.
- 了解IRI-AKI的分子机制对于开发有效的治疗方法至关重要.
- 目前对IRI-AKI机制的分析需要进一步的全面调查.
研究的目的:
- 确定参与IRI-AKI病理生理学的关键基因.
- 阐明IRI-AKI中已识别的基因的功能作用.
- 探索针对这些基因在IRI-AKI中的治疗潜力.
主要方法:
- RNA测序 (GSE153625) 用于在IRI-AKI小鼠脏中识别差异表达基因 (DEG).
- 多种算法和外部数据集 (GSE192532,GSE52004,GSE98622,GSE185383) 用于选枢纽基因.
- 用IRI-AKI小鼠模型和HK-2细胞的体外低氧/低氧化 (H/R) 来验证基因表达和功能,包括LIF基因操纵.
主要成果:
- 在IRI和虚假团体之间,共确定了1540个DEG.
- 白血病抑制因子 (LIF) 基因被确定为IRI-AKI的潜在关键调节者.
- 在IRI-AKI脏和H/R治疗的HK-2细胞中,LIF表达显著上调. LIF倒置加剧了亡和氧化应激,而LIF蛋白质的使用减轻了这些影响.
结论:
- 在IRI-AKI的早期阶段,LIF基因在调节亡和氧化应激方面发挥着重要作用.
- 准LIF为管理IRI-AKI提供了一个有希望的治疗途径.
- 对LIF机制的进一步研究可能会导致损伤的新治疗方法.
相关概念视频
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...


